Primary hypercoagulability (thrombophilia): Difference between revisions
No edit summary |
|||
| (13 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =| CurrentStatus = reconciled | | OldDxArticle = | ||
| CurrentStatus = reconciled | |||
| InitialEditorAssigned = Elaine Nagy | | InitialEditorAssigned = Elaine Nagy | ||
}} | }} | ||
{{ICD10 dx | {{ICD10 dx | ||
| MinimumCombinedCodes = | |||
| ICD10 Code=D68.5 | | ICD10 Code=D68.5 | ||
| BugRequired= | | BugRequired= | ||
}} | }} | ||
{{ICD10 category|Heme/immunology}}{{ICD10 category|Hereditary/congenital}} | |||
== Additional Info == | == Additional Info == | ||
'''Includes''' | |||
*Factor V (Factor 5, Leiden) mutation or deficiency, combine with [[Malformation/disorder NOS, congenital]] | |||
*deficiency of Protein S, Protein C | |||
*antithrombin, prothrombin gene mutation or deficiency | |||
* Hypercoagulable state NOS | |||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == | ||
*[[Hypercoagulability due to Lupus anticoagulant, anticardiolipin syndrome, antiphospholipid syndrome]] | *[[Hypercoagulability due to Lupus anticoagulant, anticardiolipin syndrome, antiphospholipid syndrome]] | ||
== Candidate [[Combined ICD10 codes]] == | |||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} | ||